Year |
Citation |
Score |
2017 |
Hassan AO, Amen O, Sayedahmed EE, Vemula SV, Amoah S, York I, Gangappa S, Sambhara S, Mittal SK. Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses. Plos One. 12: e0186244. PMID 29023601 DOI: 10.1371/Journal.Pone.0186244 |
0.729 |
|
2017 |
Vemula SV, Sayedahmed EE, Sambhara S, Mittal SK. Vaccine approaches conferring cross-protection against influenza viruses. Expert Review of Vaccines. 1-14. PMID 28925296 DOI: 10.1080/14760584.2017.1379396 |
0.731 |
|
2017 |
Ahi YS, Hassan AO, Vemula SV, Li K, Jiang W, Zhang GJ, Mittal SK. Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal. Scientific Reports. 7: 7582. PMID 28790440 DOI: 10.1038/S41598-017-07997-W |
0.504 |
|
2017 |
Hassan AO, Vemula SV, Sharma A, Bangari DS, Mishra KK, Mittal SK. 155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication. The Journal of General Virology. PMID 28086071 DOI: 10.1099/Jgv.0.000707 |
0.58 |
|
2016 |
Zhao J, Liu J, Vemula SV, Lin C, Tan J, Ragupathy V, Wang X, Mbondji-Wonje C, Ye Z, Landry ML, Hewlett I. Sensitive Detection and Simultaneous Discrimination of Influenza A and B Viruses in Nasopharyngeal Swabs in a Single Assay Using Next-Generation Sequencing-Based Diagnostics. Plos One. 11: e0163175. PMID 27658193 DOI: 10.1371/journal.pone.0163175 |
0.392 |
|
2016 |
Vemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I. Current Approaches for Diagnosis of Influenza Virus Infections in Humans. Viruses. 8. PMID 27077877 DOI: 10.3390/V8040096 |
0.497 |
|
2016 |
Mittal SK, Ahi YS, Vemula SV. Xenogenic Adenoviral Vectors Adenoviral Vectors For Gene Therapy: Second Edition. 495-528. DOI: 10.1016/B978-0-12-800276-6.00019-X |
0.577 |
|
2015 |
Amen O, Vemula SV, Zhao J, Ibrahim R, Hussein A, Hewlett IK, Moussa S, Mittal SK. Identification and characterization of a highly pathogenic H5N1 avian influenza A virus during an outbreak in vaccinated chickens in Egypt. Virus Research. 210: 337-43. PMID 26363196 DOI: 10.1016/J.Virusres.2015.09.004 |
0.693 |
|
2015 |
Ahi YS, Vemula SV, Hassan AO, Costakes G, Stauffacher C, Mittal SK. Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging. Frontiers in Microbiology. 6: 318. PMID 25954255 DOI: 10.3389/Fmicb.2015.00318 |
0.524 |
|
2015 |
Zhao J, Ragupathy V, Liu J, Wang X, Vemula SV, El Mubarak HS, Ye Z, Landry ML, Hewlett I. Nanomicroarray and multiplex next-generation sequencing for simultaneous identification and characterization of influenza viruses. Emerging Infectious Diseases. 21: 400-8. PMID 25694248 DOI: 10.3201/Eid2103.141169 |
0.459 |
|
2014 |
Zhang P, Vemula SV, Zhao J, Du B, Mohan H, Liu J, El Mubarak HS, Landry ML, Hewlett I. A highly sensitive europium nanoparticle-based immunoassay for detection of influenza A/B virus antigen in clinical specimens. Journal of Clinical Microbiology. 52: 4385-7. PMID 25297327 DOI: 10.1128/Jcm.02635-14 |
0.446 |
|
2013 |
Vemula SV, Amen O, Katz JM, Donis R, Sambhara S, Mittal SK. Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time. Virus Research. 178: 398-403. PMID 24051000 DOI: 10.1016/J.Virusres.2013.09.013 |
0.703 |
|
2013 |
Vemula SV, Pandey A, Singh N, Katz JM, Donis R, Sambhara S, Mittal SK. Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice. Virus Research. 177: 55-61. PMID 23892144 DOI: 10.1016/J.Virusres.2013.07.008 |
0.68 |
|
2013 |
Vemula SV, Ahi YS, Swaim AM, Katz JM, Donis R, Sambhara S, Mittal SK. Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. Plos One. 8: e62496. PMID 23638099 DOI: 10.1371/Journal.Pone.0062496 |
0.704 |
|
2013 |
Ahi YS, Vemula SV, Mittal SK. Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein. The Journal of General Virology. 94: 1325-34. PMID 23388198 DOI: 10.1099/Vir.0.049346-0 |
0.543 |
|
2012 |
Pandey A, Singh N, Vemula SV, Couëtil L, Katz JM, Donis R, Sambhara S, Mittal SK. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine. Plos One. 7: e33428. PMID 22432020 DOI: 10.1371/Journal.Pone.0033428 |
0.682 |
|
2012 |
Tandon M, Vemula SV, Sharma A, Ahi YS, Mittal S, Bangari DS, Mittal SK. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model. The Journal of Gene Medicine. 14: 77-89. PMID 22228563 DOI: 10.1002/Jgm.1649 |
0.56 |
|
2012 |
Tandon M, Sharma A, Vemula SV, Bangari DS, Mittal SK. Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer. Virus Research. 163: 202-11. PMID 21971215 DOI: 10.1016/J.Virusres.2011.09.031 |
0.62 |
|
2011 |
Sharma A, Bangari DS, Vemula SV, Mittal SK. Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines. Virus Research. 161: 181-7. PMID 21864589 DOI: 10.1016/J.Virusres.2011.08.002 |
0.599 |
|
2011 |
Tandon M, Vemula SV, Mittal SK. Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opinion On Therapeutic Targets. 15: 31-51. PMID 21142802 DOI: 10.1517/14728222.2011.538682 |
0.471 |
|
2010 |
Vemula SV, Mittal SK. Production of adenovirus vectors and their use as a delivery system for influenza vaccines. Expert Opinion On Biological Therapy. 10: 1469-87. PMID 20822477 DOI: 10.1517/14712598.2010.519332 |
0.687 |
|
Show low-probability matches. |